JPMorgan Chase & Co’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-600
| Closed | – | – | 5024 |
|
|
2019
Q3 | $0 | Hold |
600
| – | – | ﹤0.01% | 5016 |
|
|
2019
Q2 | $0 | Sell |
600
-1,364
| -69% | – | ﹤0.01% | 5029 |
|
|
2019
Q1 | $3K | Buy |
1,964
+1,364
| +227% | +$2.08K | ﹤0.01% | 4757 |
|
|
2018
Q4 | $1K | Hold |
600
| – | – | ﹤0.01% | 4819 |
|
|
2018
Q3 | $2K | Hold |
600
| – | – | ﹤0.01% | 4775 |
|
|
2018
Q2 | $2K | Sell |
600
-3,045
| -84% | -$10.2K | ﹤0.01% | 4703 |
|
|
2018
Q1 | $13K | Sell |
3,645
-228
| -6% | -$813 | ﹤0.01% | 4475 |
|
|
2017
Q4 | $12K | Sell |
3,873
-3,867
| -50% | -$12K | ﹤0.01% | 4476 |
|
|
2017
Q3 | $54K | Buy |
7,740
+6,336
| +451% | +$44.2K | ﹤0.01% | 3788 |
|
|
2017
Q2 | $13K | Sell |
1,404
-8,888
| -86% | -$82.3K | ﹤0.01% | 4008 |
|
|
2017
Q1 | $110K | Buy |
10,292
+6,440
| +167% | +$68.8K | ﹤0.01% | 3700 |
|
|
2016
Q4 | $32K | Buy |
+3,852
| New | +$32K | ﹤0.01% | 4087 |
|